Cart
sales@molnova.com
(E)-AG 556
CAS No. 133550-41-1
(E)-AG 556( (E)-Tyrphostin AG 556 )
Catalog No. M27474 CAS No. 133550-41-1
AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 72 | Get Quote |
|
| 25MG | 147 | Get Quote |
|
| 50MG | 222 | Get Quote |
|
| 100MG | 331 | Get Quote |
|
| 200MG | 489 | Get Quote |
|
| 500MG | 777 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(E)-AG 556
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
DescriptionAG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
In Vitro——
-
In Vivo——
-
Synonyms(E)-Tyrphostin AG 556
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133550-41-1
-
Formula Weight336.38
-
Molecular FormulaC20H20N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (297.28 mM)
-
SMILESN#C/C(/C(NCCCCc1ccccc1)=O)=C\c(cc1)cc(O)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qa'dan F, et al. Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo. J Ethnopharmacol. 2009 Jul 15;124(2):224-7.
molnova catalog
related products
-
Afatinib
An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.
-
Dacomitinib
Dacomitinib (PF-00299804, PF-299804) is a potent, irreversible, orally active pan-ErbB receptor tyrosine kinase inhibitor with IC50 of 6, 45.7 and 73.7 for EGFR, ERBB2 and ERBB4, respectively.
-
Almonertinib mesylat...
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
